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Abstract
Background—Cases with very high C-reactive protein (CRP > 10 mg/l) are often dropped from 
analytic samples in research on risk for chronic physical and mental illness, but this convention 
could inadvertently result in excluding those most at risk. We tested whether young adults with 
very high CRP scored high on indicators of chronic disease risk. We also tested intergenerational 
pathways to and sex-differentiated correlates of very high CRP.
Methods—Data came from Waves I (ages 11–19) and IV (ages 24–34) of the National 
Longitudinal Study of Adolescent Health (N=13,257). At Wave I, participants’ parents reported 
their own education and health behaviors/health. At Wave IV, young adults reported their 
socioeconomic status, psychological characteristics, reproductive/health behaviors and health; 
trained fieldworkers assessed BMI, waist circumference, blood-pressure, and medication use, and 
collected bloodspots from which high-sensitivity CRP (hs-CRP) was assayed.
Results—Logistic regressions revealed that many common indicators of chronic disease risk—
including parental health/health behaviors reported 14 years earlier—were associated with very 
high CRP in young adults. Several of these associations attenuated with the inclusion of BMI. 
More than 75% of young adults with very high CRP were female. Sex differences in associations 
of some covariates and very high CRP were observed.
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Conclusion—Especially among females, the exclusion of very high CRP cases could result in an 
underestimation of “true” associations of CRP with both, chronic disease risk indicators and 
morbidity/mortality. Very high CRP could represent an extension of the lower CRP range when it 
comes to chronic disease risk.
Keywords
C-reactive protein; inflammation; sex differences; cardiovascular disease risk; socioeconomic 
status; health disparities; intergenerational pathways; Add Health
The acute phase reactant C-reactive protein (CRP) is a marker of systemic inflammation. In 
the developed nations, values of CRP between 3 and 10 mg/L are thought to reflect elevated 
chronic low-grade inflammation and to index risk for cardiovascular and metabolic disease 
and mortality (e.g., Ridker, 2007). Values of CRP above 10 mg/L (henceforth referred to as 
“very high CRP”) are thought to primarily index temporary acute/recent infections or 
medical trauma (e.g., Pearson et al., 2003). Therefore, studies investigating the role of 
elevated low-grade systemic inflammation in chronic physical and mental illness often 
exclude cases with very high CRP (O'Connor et al., 2009) in an effort to avoid obscuring 
“true” association between CRP and disease risk (Pearson et al., 2003).
Recent research casts doubt on this practice, however, suggesting that very high CRP is not 
only associated with acute/recent medical conditions, but, in fact, is a better predictor of 
later cardiovascular disease (CVD) and all-cause mortality than CRP 3–10 mg/L (Cushman 
et al., 2005; Hamer et al., 2010; Ridker and Cook, 2004). Furthermore, very high CRP is 
associated with demographic factors and health behaviors indicative of chronic disease risk 
(Alley et al., 2006; Hamer and Chida, 2009; Ishii et al., 2012). These findings raise an 
important question about the consequences of excluding cases with very high CRP: Does 
this convention inadvertently bias analytic samples toward the disproportionate exclusion of 
those who are most at risk for chronic physical and mental illness? If so, then conclusions 
about the role of CRP in disease risk would be understated, especially for females—who 
typically have the highest levels of CRP (e.g., Ishii et al., 2012)—and for more recent 
cohorts—who suffer from higher levels of obesity compared to previous cohorts (Reither et 
al., 2011).
Here, we use a nationally representative sample to comprehensively test whether young 
adults in the United States with very high CRP score higher on indicators of chronic disease 
risk compared to their peers with lower CRP. We review 1) established correlates of very 
high CRP, 2) additional potential demographic, psychological, and health/health behavior 
correlates, and 3) potential sex differences in correlates.
Correlates of Very High CRP
Established Correlates
Several studies show that very high CRP is associated with chronic disease risk indicators 
that have previously been identified as correlates of CRP 3–10 mg/L (O'Connor et al., 
2009), including 1) lower socioeconomic status (SES; e.g., low education, income); 2) 
obesity; 3) engagement in unhealthy behaviors (e.g., smoking, low exercise/physical 
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activity); 4) Black or Hispanic race/ethnicity, 5) hypertension, and 6) depressive symptoms 
(Alley et al., 2006; Hamer and Chida, 2009; Ishii et al., 2012). Several of these correlates 
have not yet been replicated, particularly in samples of young adults.
Additional Potential Correlates
Several correlates of CRP 3–10 mg/L have not yet been established as correlates of very 
high CRP. If very high CRP represented an extension of the CRP 3–10 elevated disease risk 
continuum, then these correlates should also be associated with very high CRP. In terms of 
demographic characteristics, American Indians are at risk for elevated CRP in the < 10 
mg/L range (Shanahan et al., 2013) and also chronic CRP-associated diseases (Howard et 
al., 1999). Asian Americans typically have lower CRP levels and chronic disease risk 
(Lakoski et al., 2006). Being unpartnered/unmarried increases vulnerability to chronic 
disease—especially in males—and thus could also increase risk for very high CRP (e.g., 
Hamer and Chida, 2009; Kiecolt-Glaser et al., 2010). One final observation about 
demographic disease risk indicators is that both low SES and chronic disease are transmitted 
through generations. Thus, it is possible that dropping cases with very high CRP results in 
the exclusion of people who have been socioeconomically disadvantaged for more than one 
generation and with familial health risks.
In terms of psychological correlates, personality traits reflecting low self-control/
conscientiousness predict later low-grade inflammation and chronic illness (e.g., Moffitt et 
al., 2011) and thus potentially also very high CRP. Additional health behaviors/health 
correlates of very high CRP are possible. Diabetes could raise systemic CRP levels beyond 
the 10 mg/L threshold (Ishii et al., 2012), as could other chronic diseases, including sexually 
transmitted diseases (STD). Finally, although BMI is an established correlate of very high 
CRP, less is known about the role of waist circumference—and also additional indicators of 
metabolic syndrome such as high cholesterol—over and above BMI in associations with 
very high CRP.
Sex Differences in Correlates
Up to 70% of the very high CRP group is female; this percentage increases when repeated 
occasions of very high CRP are considered (Ishii et al., 2012). Obesity and use of oral 
contraceptives contribute to the predominance of females in the very high CRP group. 
Indeed, compared to males, females in their childbearing years encounter greater numbers of 
pro-inflammatory influences (e.g., pregnancy, oral contraceptives), stronger effects of some 
pro-inflammatory factors (e.g., BMI), and also lower levels of anti-inflammatory influences 
such as testosterone (e.g., Shanahan et al., 2013). A characterization of sex differences in 
correlates of very high CRP, however, is needed.
Methods and Materials
Participants and Procedures
Data came from Waves I and IV of the National Longitudinal Study of Adolescent Health 
(Add Health, see Harris et al., 2009). Wave I of Add Health is a nationally representative 
sample of adolescents enrolled in middle school or high school in the US in 1994. The 
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National Quality Education Database, which lists all US high schools, provided the 
sampling frame. Eighty high schools were randomly selected out of all high schools with an 
11th grade and at least enrolled 30 students. These 80 high schools were paired with middle 
schools that fed into their student body. Together, 145 schools hosted an in-school survey, 
yielding 90,118 student respondents in grades 7–12 in 1994.
Approximately 200 students from each school were randomly selected for in-depth in-home 
interviews, resulting in N=20,745 (Wave I). The in-home assessments included interviews 
with a parent (typically the mother/female head of the household). Parental reports used in 
our study were drawn from these interviews. Wave IV was collected when respondents were 
24–34 years old (14 years after Wave I). Of the eligible respondents from Wave I, 93% were 
re-located and 80% were re-interviewed, resulting in 15,701 in-home interviews. Wave IV 
blood samples were obtained at the end of each interview by trained and certified field 
workers using a finger-prick procedure, as described the Add Health documentation (Harris 
and Udry, 2013). Dried blood spots were mailed to and assayed at the University of 
Washington Medical Center Immunology Lab. Written consent was obtained from parents/
guardians (Wave I) and young adults (Wave IV); written assent was obtained from 
adolescents (Wave I).
Assessment
C-reactive Protein—An in-depth documentation of the Add Health hs-CRP assay and 
quality control are available online (Whitsel et al., 2013). Briefly, a sandwich ELISA 
method was adapted from a previously published method (McDade et al., 2004). Values 
from dried blood spots and paired plasma samples were highly correlated (r = .98) in a 
cross-validation study. Intra-assay variation was 8.1% and inter-assay variation was 11%. 
We created a dichotomous measure of very high CRP (0 = ≤ 10 mg/L, 1 = > 10 mg/L. For 
select supplemental analyses, we also created dichotomous elevated hs-CRP < 3 mg/L and 
hs-CRP 3–10 mg/L variables.
Demographics variables: Dummy variables coded different racial/ethnic groups: Hispanic, 
Black, Asian, American Indian, other, and White (reference category). Parental education 
(Wave I) coded the highest level of education completed by either parent, ranging from 0 = 
≤ 8th grade to 5 = professional training beyond a four-year college/university. Parental 
income had a substantial amount of missing data; therefore, it was not included here. Three 
dummy variables for parental self-reports of health behaviors/health (Wave I) coded if a 
residential parent reported currently smoking, and if a biological parent reported having 
been diagnosed with diabetes or being obese.
Young adults reported their socioeconomic and marital/cohabitation status (Wave IV). 
Household income measured total income from all sources before taxes/deductions, and was 
log-transformed to lessen the impact of extremely high incomes on statistical estimates. The 
coding of subjects’ education was identical to that of parental education. Participants 
reported whether they were married, cohabiting, or single (=reference category).
Psychological Characteristics (Wave IV): Lifetime Depression/Anxiety: Subjects reported 
whether a health care provider had ever told them that they had a depressive and/or anxiety 
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disorder. Conscientiousness was assessed using the Mini-IPIP (for a description of the latent 
conscientiousness score used here, see Baldasaro et al., 2013). Briefly, four items, measured 
on a scale from 1=strongly disagree to 5=strongly agree, were used. Health behaviors 
(Wave IV). A dummy variable coded whether participants had smoked ≥ 1 cigarette/day in 
the past month. A continuous variable coded the number of times subjects reported having 
participated in physical activities (e.g., running, bicycling, weightlifting) in the past 7 days, 
with 0=no physical activity to 3 ≥ 3 physical activities. Alcohol use was assessed on a 6-
point scale, with 0=no drink in the past 12 months to 6=drinking (almost) every day.
Reproductive Variables (Wave IV): A dichotomous current pregnancy coded whether a 
female reported currently being pregnant. Number of children counted the number of 
biological children to date. Females reported on their use of oral contraceptives. Males 
received a score of 0 on the pregnancy and oral contraceptives variables.
A dichotomous Acute illness (Wave IV) variable coded whether the participant reported 
having had any of the following illnesses within the previous two weeks: cold, fever, sweats, 
nausea, blood in stool or urine, frequent urination, or skin rash/abscess. Surgery indicated 
whether the subject had surgery in the past 4 weeks. Chronic illness was generally assessed 
using the following script: “Has a doctor, nurse or other health care provider ever told you 
that you have or had: [DISEASE].”). Diabetes coded self-reported lifetime diagnosis of high 
blood sugar or diabetes. A dichotomous non-diabetic chronic illness variable coded the 
presence of any of the following self-reported lifetime diagnoses: heart disease, cancer, 
asthma, migraines, hepatitis and gum disease. Sexually transmitted disease (STD) summed 
self-reported lifetime diagnoses, including chlamydia, gonorrhea, trichomoniasis, syphilis, 
genital herpes, genital warts, human pampilloma virus, pelvic inflammatory disease, 
cervicitis or mucopurulent cervicitis, urethritis, vaginitis and human immunodeficiency 
virus. Additional illness variables are available in Add Health, but we limited our focus to 
conditions that were theoretically linked with inflammation and/or showed bivariate 
associations with very high CRP. Follow-up analyses using illness variables provided in the 
Add Health online documentation showed that changes in substantive results reported here 
were negligible.
Medication use was primarily recorded by interviewers from medications/containers 
provided by participants. A minority of participants recalled their medication use. For 
parsimony’s sake, we created a dummy variable which coded whether any non-prescription 
or prescription medication had been taken. Follow-up analyses suggested that changes in 
substantive results were negligible when medication use was disaggregated into the more 
specific categories available in Add Health (e.g., non-steroidal anti-inflammatory drugs). 
Body mass index (BMI; Wave IV) was calculated as weight (kg)/height (m2)—which were 
measured by trained field workers. A squared BMI term was created in order to indicate 
extreme obesity (Ishii et al., 2012). Metabolic syndrome indicators (Wave IV). Waist 
circumference (in centimeters) and resting blood pressure were assessed by trained 
interviewers. The dichotomous cholesterol measure coded self-reported lifetime diagnosis of 
elevated cholesterol.
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N=1,640 respondents did not consent to having blood samples taken or had physical injuries 
preventing blood sample collection; N=903 respondents did not have a valid sample weight; 
and N=2 subjects had missing data on sex—resulting in an analytic sample of N=13,257. 
Parental health variables had significant amounts of missing data (e.g., N=1,802 missing 
data on parental smoking), and multiple imputation by chained equations (MICE) was used 
to impute missing values. MICE uses a series of imputation models fitted to each variable to 
estimate missing cases based on the arbitrary patterns for continuous, binary, ordinal, 
cardinal, or count variables (e.g., White et al., 2011). Specifically, we estimated 5 datasets 
based on all the variables in our models, and report estimates that are averaged across these 
datasets.
Analytic Strategy
Analyses were conducted in Stata 12 using the survey suite of commands that use sample 
weights and adjust for the clustered sampling design. The primary objective of our analyses 
was to better understand whether and how the group that is often excluded from analytic 
samples (i.e., the CRP > 10 mg/L group) systematically differs from the analytic samples 
typically used (i.e., the CRP ≤ 10 mg/L group) on chronic disease risk indicators. Therefore, 
we first tested bivariate associations of all study variables with very high CRP. Specifically, 
we used weighted logistic regression analyses to predict membership in the very high CRP > 
10 mg/l versus the lower CRP (≤ 10 mg/L) group. Next, because indicators of chronic 
disease risk typically covary, we conducted a series of nested logistic regression models that 
sequentially added demographic, psychological, and health/reproductive behavior correlates 
to multivariate models (Models 1–6). Model 1 included basic demographic correlates (age, 
sex, race/ethnicity). Model 2 included indicators of parental education and health/health 
behaviors. Models 3–5 included indicators of subjects’ own SES, psychological 
characteristics, and health behaviors, thus allowing us to approximate potential 
intergenerational pathways from parent SES to very high CRP via subject SES, 
psychological characteristics, and health behaviors. Model 6 added reproductive variables.
Model 7 added acute illness, chronic illness and medication use variables. If very high CRP 
was an indicator of acute inflammatory conditions/medication use only, then these variables 
should account for any associations observed in the previous models. Finally, Models 8–9 
entered BMI and metabolic syndrome indicators. If very high CRP was an indicator of 
chronic inflammation and disease risk, as suggested by Ishii and colleagues (2012), then 
many differences between the very high and lower CRP groups should no longer be 
significant when BMI—a major chronic disease risk that clusters with many additional 
disease risk indicators—is taken into account. In a final analysis, we tested interactions 
between all study variables and sex, testing one interaction at-a-time.
Results
Twelve percent (N = 1,693) of young adults had very high CRP. This estimate is similar to 
the 10% reported by the CARDIA study of young adults—which was calculated after 
excluding participants with acute illness and current pregnancy (Ishii et al., 2012). Seventy-
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six percent of the very high CRP group was female, replicating the preponderance of 
females in this group (Ishii et al., 2012). Looking within each sex category, 18% of females 
(N=1,297) and 6% of males (N=396) had very high CRP. Descriptive statistics for all study 
variables are reported in Table 1, showing, for example, a greater than 7 point difference in 
BMI, and an almost 15 cm difference in waist circumference between the very high (> 10 
mg/L) and lower (≤ 10 mg/L) CRP groups. Supplement 1 further breaks down basic 
descriptive statistics for the CRP < 3, CRP 3–10 and CRP > 10 groups. The descriptives 
shown in Supplement 1 illustrate that almost all chronic disease risk indicators increase 
across these three CRP groups, supporting the idea that in generally healthy samples from 
the community very high CRP may be part of a chronic disease risk continuum.
Bivariate associations of all covariates with very high CRP (versus CRP ≤ 10mg/L) are 
reported in the first column of Table 2; the odds ratios were derived from weighted logistic 
regression analyses. The majority of covariates were associated with very high CRP. 
Previously identified correlates of very high CRP were replicated in this nationally 
representative sample of young adults, and new ones were identified (e.g., non-Asian 
American race; low parental education; parental smoking, diabetes and obesity; lifetime 
depression/anxiety diagnosis; low conscientiousness; recent surgery; diabetes; STD; high 
waist circumference, high cholesterol).
In Model 1, females, Hispanics, Blacks, and American Indians were over-, and Asians were 
under-represented in the very high CRP group. In Model 2, low parental education, and 
parental smoking and obesity—assessed 14 years earlier—predicted very high CRP, and 
attenuated the effect of American Indian ethnicity in the remaining models. In Model 3 
young adult SES was significant. In this model, the odds ratio for parental education was 
attenuated to non-significance for the remainder of the models. In Model 4, lifetime 
depression/anxiety disorder and low conscientiousness predicted very high CRP. In Model 
5, lower levels of alcohol use and physical activity were associated with very high CRP.
In Model 6 each reproductive variable independently predicted very high CRP. Number of 
children had not been significant in bivariate models (but could reflect a selection effect of 
healthier adults having more children here). In Model 7, acute illness, recent surgery, 
diabetes, and medication use were associated with very high CRP, and attenuated the effect 
of lifetime depression/anxiety and low conscientiousness for the remaining models. 
Importantly, Model 7 did not attenuate any other correlates of very high CRP to non-
significance. This was also the case when acute illness, chronic illness, and medication use 
were added in separate steps.
In Model 8, both BMI and BMI2 were associated with very high CRP, documenting non-
linear associations. In order to interpret this effect, we re-ran Model 8 with categorical BMI 
indicators. Results suggested that being severely obese at BMI 35+ was most strongly 
associated with very high CRP (OR = 8.58). In comparison, the odds ratios for underweight 
(BMI< 18.5), overweight (BMI=25–29.9), and obese (BMI=30–34.9) were at 0.74, 1.80 and 
2.82, respectively. Importantly, adding BMI attenuated the effects of African American race, 
parental smoking and obesity, and young adults’ income, education and diabetes to non-
significance. Thus, the associations between these six indicators of chronic disease risk and 
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very high CRP appeared to operate through their associations with BMI. In Model 9, waist 
circumference was associated with very high CRP, and attenuated the effect of BMI2 
partially, but not fully. In this final comprehensive model, several differences between the 
very high and lower CRP groups remained. Female sex, Hispanic ethnicity, low physical 
activity, fewer children, use of oral contraceptives, acute illness, recent surgery, medication 
use, BMI/BMI2 and waist circumference remained associated with very high CRP.
Sex Differences Analyses
We tested sex differences in covariates by including covariate by sex interactions (one-at-a-
time) in the prediction of very high CRP in Model 9. We report the significant covariate X 
sex interactions here; Supplement 2 also shows results from bivariate models and Model 9 
for females and males separately. Several variables were protective from very high CRP in 
males, but not females: Asian race (p < .001) and being married (p < .01). Other variables 
were associated with increased risk for very high CRP in females, but not males: BMI (p < .
05), BMI2 (p < .05), use of oral contraceptives and currently being pregnant. Yet other 
variables were more strongly positively associated with very high CRP in males than in 
females: acute illness (p < .001), recent surgery (p < .01), and medication use (p < .001). In 
addition, waist circumference was positively associated with very high CRP in males, but 
not females (p < .05). The results in Supplement 2 also suggest additional potential sex 
differences (i.e., Hispanic and American Indian race/ethnicity as significant positive 
covariates of very high CRP in females only), but statistical interactions between these race/
ethnicity variables and sex were not significant.
Follow Up Analyses
Sensitivity analyses excluded participants with ≥ 1 acute illness and also with ≥ 2 acute 
illnesses and also repeated all analyses with non-imputed datasets using list-wise deletion. 
The overall pattern of results did not change in these sensitivity analyses. An additional set 
of analyses (shown in Supplement 3) gauged changes in effect sizes that occur when the 
very high CRP group is excluded from analytic samples. Specifically, weighted logistic 
regression analyses were conducted predicting CRP ≥ 3 mg/L—the conventional cut-off for 
high CRP—using CRP < 3 mg/L as the comparison category. In a first set of bivariate 
analyses, cases with CRP > 10 mg/L were excluded. In a second set of analyses, these cases 
were included. We compared the odds ratios from these two sets of analyses.
The full results for the overall sample, females, and males are available in Supplement 3. As 
expected, the changes in odds ratios were the greatest in the female subsample. Specifically, 
the size of the association for the following (dichotomized) variables was underestimated by 
≥ 10% when the very high CRP group was excluded (see Table 1a on p. 4 in Supplement 3): 
Hispanic (13%), Black (15%), American Indian (28%), parental diabetes (12%), parental 
obesity (11%), alcohol use (15%), surgery (21%), diabetes (34%), severe obesity (46%), 
high waist circumference (36%), high systolic blood pressure (11%), high cholesterol 
(14%). In many samples—especially those smaller than the Add Health sample—these and 
smaller changes in effect size could contribute to whether or not a variable emerges as a 
significant correlate of elevated CRP.
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Approximately 5–15% of participants in adult samples in the US exceed the CRP > 10 mg/L 
cut-off; 18% of females and 6% of males were classified as very high CRP in Wave IV of 
the National Longitudinal Study of Adolescent Health. Our analyses identified novel 
bivariate correlates of very high CRP in young adults, including American Indian and non-
Asian American race; low parental education; parental diabetes and obesity; lifetime 
depression/anxiety diagnosis; low conscientiousness; recent surgery; STD; high waist 
circumference; and high cholesterol. Several findings from our study especially warrant 
discussion.
First, BMI—not acute illness, medical trauma or medication use—was the key variable that 
accounted for a number of differences between the very high and lower CRP groups. Indeed, 
consistent with previous research, severely obese young adults were over-represented in the 
very high CRP group (Ishii et al., 2012). BMI did not appear to be an ideal indicator of 
health-related adiposity in males—for whom only waist circumference (not BMI) was 
associated with very high CRP in final models. Notably, the health-related adiposity 
measures did not explain all differences between the very high and lower CRP groups. 
Factors accounting for these remaining differences need to be investigated, including body 
fat distribution, endogenous sex hormones, and also genetic and epigenetic factors.
Second, we replicated the female preponderance in the very high CRP group, and were able 
to partially explain it. Several variables encountered by females only (e.g., oral 
contraceptives, pregnancy) were associated with very high CRP. Other variables (e.g., BMI, 
BMI2) were more strongly associated in females than in males. Additional factors (e.g., 
being Asian, married) were protective from very high CRP in males, but not females. In Add 
Health, almost 20% of females would be excluded when following current conventions in 
CRP research. Our follow-up analyses suggested that potential bias from excluding the very 
high CRP group is most pronounced in young adult females—a group that already suffers 
from under-detection of CVD and for whom mortality from CVD has declined the least in 
recent decades (Ford and Capewell, 2007).
Indeed, what constitutes low-grade inflammation in females and the utility of using very 
high CRP as an indicator of disease risk for this group needs to be re-evaluated (Ishii et al., 
2012; Shanahan et al., 2013). Older females with very high CRP were 8 times more likely to 
have future cardiovascular events compared to their lowest CRP counterparts; these results 
need to be followed up with younger samples (Ridker and Cook, 2004). Our findings that 
acute medical conditions and medication use were more strongly associated with very high 
CRP in males than in females suggest that, perhaps, CRP >10 mg/L is a better indicator of 
acute conditions in males than in females.
A third notable finding from our study was first, preliminary evidence for intergenerational 
effects, especially from parental health/health behaviors to young adult BMI and very high 
CRP. These findings point to the possibility that the exclusion of cases with very high CRP 
from analytic samples could disproportionally exclude those who have had elevated chronic 
disease risk for at least two generations. Considering the 14-year lag between the 
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assessments of the parental health/health behavior predictors and offspring’s very high CRP 
outcome, these findings also further undermine the idea that very high CRP is merely 
reflective of acute conditions.
Consequences of Excluding the Very High CRP Group from Analytic Samples
Our study suggests that excluding the very high CRP group from analytic samples in health 
research disproportionally bases findings on those with the lowest levels of chronic disease 
risk – with better education and health behaviors/health for at least two generations, lower 
BMI/waist circumference and associated disease risks, and also fewer psychological 
characteristics that predict increased disease risk. Very high CRP is often excluded from 
research because of the concern that it is indicative of “random” acute illness only. If this 
assumption were true, then including cases with very high CRP could “obscure any 
prediction of coronary” and other disease risks (p. 11, Pearson et al., 2003). Our results, 
however, suggest that it could, in fact, be the exclusion of this group that could obscure 
associations and the “true” size of effects between CRP and chronic disease risks—
especially in females. Weakened effect sizes that result from the exclusion of very high CRP 
group could contribute to inconsistent patterns of covariate-CRP associations across studies 
(e.g., significance of associations in some, but not other studies).
How can research studies address the possibility that very high CRP may be an extension of 
the CRP continuum past the 10 mg/L range rather than a qualitatively different state that can 
simply be discarded from analytic samples? Results from analyses with and also without the 
very high CRP group should be reported in order to allow others to gauge differences in the 
resultant effect sizes of associations. Alternatively, cases with very high CRP could be 
incorporated in studies that can adjust analyses for acute/recent infections and medication 
use. In such studies, the distributions of the continuous CRP variable need to be carefully 
inspected considering that values of CRP > 10 mg/L can be widely dispersed. The accuracy 
of the high-sensitivity assay could also decline in the very high CRP range; thus, the use of 
categorical CRP variables may be warranted.
In clinical settings, a reasonable recommendation in response to a measurement of very high 
CRP is to measure CRP a second time (Pearson et al., 2003). Repeated measurements of 
very high CRP—that co-occur with other traditional risk factors for CVD—could be useful 
in flagging particularly high levels of chronic disease risk, perhaps especially in females.
Limitations
The Add Health study currently only has one assessment of CRP and thus chronicity and/or 
predictors of future very high CRP could not be tested. Furthermore, variables not easily 
assessed in field research, including total amounts and distribution of body fat, physical 
fitness, and dietary intake were not available. The measurement of some variables was also 
not ideal. For example, self-reported lifetime diagnoses are subject for forgetting and likely 
result in underreporting (Moffitt et al., 2009). In addition, although measures assessing 
chronic illness asked whether a health care provider had previously diagnosed a given 
illness, additional standardized, physician-verified assessments of these conditions would be 
preferable. Nevertheless, studies comparing physician assessments with self-assessments of 
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health report that the latter is an “equal or superior” predictor of later health and mortality 
(Ferraro and Farmer, 1999). Finally, many statistical tests were conducted in our effort to 
comprehensively characterize the very high CRP group, increasing the risk of chance 
findings. However, had we applied p < .01 or even p < .001 criteria, most correlates of very 
high CRP identified here—including correlates in the bivariate and in the final models—
would have remained significant.
Despite these limitations, our study provides a more thorough characterization of young 
adults with very high CRP than has previously been possible, and suggests that a careful 
reconsideration of how to meaningfully include these cases in studies of the development of 
chronic physical and mental illness is needed.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Means (SD) and N (weighted %) of all covariates in the lower and very high CRP groups. All estimates based 
on datasets created with multiple imputation.






Categorical Variables Weighted % Weighted %
Female 47% 76%




American Indian 2% 3%
Other 1% 1%
Parental Smoking 30% 35%
Parental Diabetes 8% 11%
Parental Obesity 22% 32%





Currently Pregnant 3% 6%
Oral Contraceptive 15% 26%
Acute Illness 33% 48%
Recent Surgery 2% 4%
Diabetes 2% 5%
Non-diabetic Chronic Illness 29% 36%
Medication Use 29% 37%
High Cholesterol 8% 11%
Continuous Variables Mean Mean
Age (Years) 28.42 28.45
Parental Education 2.89 2.66
Logged Household Income 10.76 10.56
Education Level 3.06 2.91
Conscientiousness <0.01 <0.01
Drinking 2.37 1.82
Physical Activity 1.75 1.50
Number of children 0.87 0.95
# of sexually transmitted diseases 0.30 0.40
BMI 28.36 35.66
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Waist Circumference 96.95 111.66
Systolic Blood Pressure 124.96 125.97
Diastolic Blood Pressure 79.31 80.58
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